Approach to the pharmacological management of chronic pain in patients with an alcohol use disorder

References

• HoffmannNGOlofssonOSalenBWickstromLPrevalence of abuse and dependency in chronic pain patientsInt J Addict19953089199277558484
   PubMed Web of Science ®Google Scholar
• JakubczykAIlgenMABohnertASPhysical pain in alcohol-dependent patients entering treatment in Poland-prevalence and correlatesJ Stud Alcohol Drugs201576460761426098037
   PubMed Web of Science ®Google Scholar
• BrennanPSchutteKSooHooSMoosRHPainful medical conditions and alcohol use: a prospective study among older adultsPain Med2011121049105921668742
   PubMed Web of Science ®Google Scholar
• ZaleEMaistoSDitreJInterrelations between pain and alcohol: an integrative reviewClin Psychol Rev201537577125766100
   PubMed Web of Science ®Google Scholar
• National Opioid Use Guideline Group (NOUGG)Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer PainHamilton, ONNOUGG2010 Available from: http://nationalpaincentre.mcmaster.ca/opioid/Accessed March 9, 2012
   Google Scholar
• MoulinDEBoulangerAClarkAJPharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain SocietyPain Res Manag201419632833525479151
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol2010179e1113e1188
   PubMed Web of Science ®Google Scholar
• Lexi-Comp Online™, Lexi-Interact™Hudson, OHLexi-Comp, Inc2015
   Google Scholar
• Micromedex® Healthcare Series (nd)Greenwood Village, COThomson Healthcare Available from: http://www.thomsonhc.comAccessed March 9, 2012
   Google Scholar
• KalapatapuRKChambersRNovel objective biomarkers of alcohol use: potential diagnostic and treatment management tools in dual diagnosis careJ Dual Diagn200951578220582236
   PubMed Web of Science ®Google Scholar
• SAMHSA AdvisoryThe Role of Biomarkers in the Treatment of Alcohol Use Disorders2012112 Available from: http://store.samhsa.gov/shin/content/SMA12-4686/SMA12-4686.pdfAccessed August 27, 2015
   Google Scholar
• SchmidtLEDalhoffKPoulsenHEAcute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicityHepatology200235487688211915034
   PubMed Web of Science ®Google Scholar
• DartRCGreenJLKuffnerEKHeardKSprouleBBrandsBThe effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol – a randomized studyAliment Pharmacol Ther201032347848620491750
   PubMed Web of Science ®Google Scholar
• KuffnerEKDartRCBogdanGMHillRECasperEDartonLEffect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trialArch Intern Med2001161182247225211575982
   PubMed Web of Science ®Google Scholar
• KuffnerEKGreenJLBogdanGMThe effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients – a multicenter randomized studyBMC Med200751317537264
   PubMed Web of Science ®Google Scholar
• RumackBHeardKGreenJEffect of therapeutic doses of acetaminophen (up to 4 g/day) on serum alanine aminotransferase levels in subjects consuming ethanol: systematic review and meta-analysis of randomized controlled trialsPharmacotherapy201232978479122851428
   PubMed Web of Science ®Google Scholar
• HeardKGreenJLBaileyJEBogdanGMDartRCA randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcoholAliment Pharmacol Ther200726228329017593074
   PubMed Web of Science ®Google Scholar
• LynchMEWatsonCPThe pharmacotherapy of chronic pain: a reviewPain Res Manag2006111113816511612
   PubMedGoogle Scholar
• FarhadiAKeshavarzianAKwasnyMJEffects of aspirin on gastroduodenal permeability in alcoholics and controlsAlcohol201044544745620598487
   PubMed Web of Science ®Google Scholar
• LaineLWeinsteinWMHistology of alcoholic hemorrhagic “gastritis”: a prospective evaluationGastroenterology1988946125412623258836
   PubMed Web of Science ®Google Scholar
• KellyJPKaufmanDWKoffRSLaszloAWiholmBEShapiroSAlcohol consumption and the risk of major upper gastrointestinal bleedingAm J Gastroenterol1995907105810647611196
   PubMed Web of Science ®Google Scholar
• NeutelCIAppelWCThe effect of alcohol abuse on the risk of NSAID-related gastrointestinal eventsAnn Epidemiol200010424625010854958
   PubMed Web of Science ®Google Scholar
• HuntRHChoquetteDCraigBNApproach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?Can Fam Physician20075371177118417872814
   PubMed Web of Science ®Google Scholar
• RostomAMoayyediPHuntRCanadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risksAliment Pharmacol Ther200929548149619053986
   PubMed Web of Science ®Google Scholar
• JonesCMPaulozziLJMackKAAlcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths – United States, 2010MMWR Morb Mortal Wkly Rep2014634088188525299603
   PubMed Web of Science ®Google Scholar
• JohnsonFWagnerGSunSStaufferJEffect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsulesJ Pain20089433033618201934
   PubMed Web of Science ®Google Scholar
• WaldenMNichollsFASmithKJTuckerGTThe effect of ethanol on the release of opioids from oral prolonged-release preparationsDrug Dev Ind Pharm200733101101111117882730
   PubMed Web of Science ®Google Scholar
• TraynorMJBrownMBPannalaABeckPMartinGPInfluence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experimentsDrug Dev Ind Pharm200834888588918618305
   PubMed Web of Science ®Google Scholar
• SathyanGSivakumarKThipphawongJPharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcoholCurr Med Res Opin200824129730518062845
   PubMed Web of Science ®Google Scholar
• IvesTJChelminskiPRHammett-StablerCAPredictors of opioid misuse in patients with chronic pain: a prospective cohort studyBMC Health Serv Res200664616595013
   PubMed Web of Science ®Google Scholar
• TurkDCSwansonKSGatchelRJPredicting opioid misuse by chronic pain patients: a systematic review and literature synthesisClin J Pain200824649750818574359
   PubMed Web of Science ®Google Scholar
• ReVia™ [monograph online]Compendium of Pharmaceuticals and Specialties, online version (e-CPS)Ottawa, ONCanadian Pharmacists Association2012 Available from: http://www.e-therapeutics.ca/Accessed March 15, 2012
   Google Scholar
• SwiftREmerging approaches to managing alcohol dependenceAm J Health Syst Pharm2007645 Suppl 3S12S2217322178
   PubMed Web of Science ®Google Scholar
• PettinatiHMAntidepressant treatment of co-occurring depression and alcohol dependenceBiol Psychiatry2004561078579215556124
   PubMed Web of Science ®Google Scholar
• AltintoprakAEZorluNCoskunolHAkdenizFKitapciogluGEffectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind studyHum Psychopharmacol200823431331918327889
   PubMed Web of Science ®Google Scholar
• MaanyIHayashidaMPfefferSLKronREPossible toxic interaction between disulfiram and amitriptylineArch Gen Psychiatry19823967437447092508
   PubMed Web of Science ®Google Scholar
• Cymbalta® [monograph online]Compendium of Pharmaceuticals and Specialties, online version (e-CPS)Ottawa, ONCanadian Pharmacists Association2012 Available from: http://www.e-therapeutics.caAccessed May 23, 2012
   Google Scholar
• Effexor® [monograph online]Compendium of Pharmaceuticals and Specialties, online version (e-CPS)Ottawa, ONCanadian Pharmacists Association2015 Available from: http://www.e-therapeutics.caAccessed August 23, 2015
   Google Scholar
• TroySPiergiesALuckiIVenlafaxine pharmacokinetics and pharmacodynamicsClin Neuropharmacol199215Suppl 1B324B
   Google Scholar
• BrowerKJMyra KimHStrobbeSKaram-HageMAConsensFZuckerRAA randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomniaAlcohol Clin Exp Res20083281429143818540923
   PubMed Web of Science ®Google Scholar
• AntonRFMyrickHWrightTMGabapentin combined with naltrexone for the treatment of alcohol dependenceAm J Psychiatry2011168770971721454917
   PubMed Web of Science ®Google Scholar
• GuglielmoRMartinottiGClericiMJaniriLPregabalin for alcohol dependence: a critical review of the literatureAdv Ther2012291194795723132700
   PubMed Web of Science ®Google Scholar
• PerraSPillollaGMelisMMuntoniALGessaGLPistisMInvolvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivoPsychopharmacology (Berl)2005183336837716228194
   PubMed Web of Science ®Google Scholar
• ColomboGSerraSVaccaGCaraiMAGessaGLEndocannabinoid system and alcohol addiction: pharmacological studiesPharmacol Biochem Behav200581236938015939463
   PubMed Web of Science ®Google Scholar
• HungundBLBasavarajappaBSRole of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviorsAnn N Y Acad Sci2004102551552715542757
   PubMed Web of Science ®Google Scholar
• LukasSEOrozcoSEthanol increases plasma Delta(9)-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteersDrug Alcohol Depend200164214314911543984
   PubMed Web of Science ®Google Scholar
• SeamonMJFassJAManiscalco-FeichtlMAbu-ShraieNAMedical marijuana and the developing role of the pharmacistAm J Health Syst Pharm200764101037104417494903
   PubMed Web of Science ®Google Scholar
• RobbeHMarijuana’s impairing effects on driving are moderate when taken alone but severe when combined with alcoholHum Psychopharmacol199813Suppl 2S70S78
   Web of Science ®Google Scholar